Nutex Health price to free cash flow NUTX
Market value divided by free cash flow over the last twelve months, since 2023.
- Today, Nov 2, 2026
- 4.6×
- 4-year median
- 9.0×
- Against its 4-year history
- 17th
- percentile: 0 is its lowest day, 100 its highest
- 4-year range
- 2.5× to 316×
- Peer median
- 12.8×
Nutex Health's price to free cash flow is 4.6× as of Nov 2, 2026.
That is below its 4-year median of 9.0×, lower than on 83% of days in the last 4 years.
Over that time it ranged from 2.5× in Mar 2026 to 316× in Nov 2023.
The median for 10 credit services stocks of a similar size is 12.8×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 4.6× | 2.5× | 7.5× |
| 2025 | 7.1× | 4.6× | 39.5× |
| 2024 | 8.6× | 3.9× | 277× |
| 2023 | 237× | 71.2× | 316× |
Against its peers
Companies in Financial - Credit Services nearest Nutex Health's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| NUTXNutex Health | 4.6× |
| WDWalker & Dunlop | n/m |
| JCAPJefferson Capital | n/m |
| LQDTLiquidity Services | 15.5× |
| ATLCAtlanticus | n/m |
| PWPPerella Weinberg Partners | 14.1× |
| PGYPagaya Technologies | 6.0× |
| QNSTQuinstreet | 7.8× |
| RHLDResolute Holdings Management | 11.5× |
| HAPNHappen | n/m |
| MAXMediaAlpha | 16.1× |
| Peer median | 12.8× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Nutex Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.